PR Newswire Clinical TrialsOriginal article
Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing
Positive
AI Analysis
Summary
Partillion Bioscience secured a $2.1 million NIH SBIR grant for a two-year period to advance Cell-Cell-seq technology, marking the company's tenth such award and bringing total non-dilutive federal funding to over $8 million.
Importance:3/10
Sentiment:
0.60
fundingNIH SBIRnon-dilutive capitalcell biologysequencing technology
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 9, 2026 11:15 AM
